Production operators stand by tubes in a bioreactor as they prepare a cell culture for growing active Ebola vaccine substances in the laboratory of Bavarian Nordic A/S in Kvistgaard, Denmark. The vaccine, to combat the virus that has killed thousands in West Africa, combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Danish biotechnology company Bavarian Nordic, J&J said.